Development of an ELISA to measure soluble CD163 in biological fluids.
about
Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type AElevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect.The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage.Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem CellsCD163 promotes hematoma absorption and improves neurological functions in patients with intracerebral hemorrhage.Effect of bone marrow mesenchymal stem cell transplantation on acute hepatic failure in rats.Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis.Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries.Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163.Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region.
P2860
Q24306764-01CF1131-CE1D-4959-BBE2-0BC37C4CB2F9Q24681059-CD5F5F26-BB00-480F-9D85-4B8D9B8C9A79Q34147333-95CA661A-2BBE-4D63-B20B-9944E12A5C71Q34652179-A6E0212B-073D-46F5-B033-55860CDAFE3EQ36141369-0339E527-3315-4831-A6D6-938419E6AC80Q36182364-5475C5C6-3CE2-4411-8A7B-FA5622DC9E99Q37196512-1EF468A5-0046-44A2-85A1-42618313C5ADQ41754256-5E3E9A0F-83E2-425F-B818-B091B0382A21Q42280585-5DF04CC5-5484-4625-B807-58FBBA0CB114Q42750527-573B1A86-BE8F-4FE9-9043-962366E2A301Q42921094-A2F9C5DA-54B7-4BE5-AE9C-8D7675A09FFDQ44838325-25228DF7-1177-4B5E-B4EA-E3F6E830E9B3Q45078050-B2913CF4-06BA-444D-B90A-083095B7BC35
P2860
Development of an ELISA to measure soluble CD163 in biological fluids.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of an ELISA to measure soluble CD163 in biological fluids.
@ast
Development of an ELISA to measure soluble CD163 in biological fluids.
@en
type
label
Development of an ELISA to measure soluble CD163 in biological fluids.
@ast
Development of an ELISA to measure soluble CD163 in biological fluids.
@en
prefLabel
Development of an ELISA to measure soluble CD163 in biological fluids.
@ast
Development of an ELISA to measure soluble CD163 in biological fluids.
@en
P2093
P1476
Development of an ELISA to measure soluble CD163 in biological fluids.
@en
P2093
P356
10.1016/S0022-1759(01)00328-3
P577
2001-06-01T00:00:00Z